29
total announcements
TATVA.NS · 15 min delayed
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has made available the recording of its earnings call held on July 17, 2026, on its website.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Investor Presentation for the quarter ended 30June2026, with consolidated financial highlights showing a 43% YoY increase in revenue from operations to ₹1,671 crore, and a 86% YoY increase in EBITDA to ₹323 crore.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Capacity addition. The Board has approved the proposed capacity expansion (addition) of manufacturing capacities of various specialty chemicals at the new greenfield unit at Dahej - III, Dahej Industrial Estate, Taluka: Vagra, District: Bharuch, Gujarat, India.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Change in Director(s) of the company, including the re-appointment of three directors and the approval of a proposed capacity expansion and increase in borrowing limits.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and announced the re-appointment of its Managing Director and Whole-time Directors for a further period of three years. The company also approved a capacity expansion of its manufacturing capacities and an increase in its borrowing limits.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an earnings call post announcement of financial results for the quarter ended 30 June 2026. The call is hosted by ICICI Securities and is scheduled on Friday, 17 July 2026, at 05:00 p.m. (IST).
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialisation during the quarter ended 30 June 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure, effective from July 1, 2026, will remain in effect until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. This action is a standard compliance measure under SEBI (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing insider trading before financial disclosures. Such intimations are routine regulatory filings.